Historical background and evolution of pharmacovigilance

 Historical Background and Evolution of Pharmacovigilance

1. Early Beginnings: The roots of pharmacovigilance can be traced back to historical events where adverse effects of medications were observed and documented. For instance, in the 1960s, the thalidomide tragedy, which led to severe birth defects in infants born to mothers who had taken the drug for morning sickness, highlighted the need for systematic monitoring of drug safety.

2. Formalization of Pharmacovigilance: The formalization of pharmacovigilance began in the 1960s and 1970s with the establishment of pharmacovigilance programs and regulatory frameworks in various countries. The U.S. FDA introduced its Adverse Drug Reaction Reporting System in 1968, marking a significant step in systematic monitoring of drug safety.

3. International Collaboration: The need for international collaboration in pharmacovigilance became evident as the pharmaceutical industry expanded globally. In 1968, the World Health Organization (WHO) launched the Programme for International Drug Monitoring, which established a network of national pharmacovigilance centers to facilitate the exchange of information on adverse drug reactions (ADRs) worldwide.

4. Regulatory Initiatives: Regulatory agencies around the world started to emphasize the importance of pharmacovigilance as an integral part of drug regulation. Guidelines and regulations, such as the International Conference on Harmonisation (ICH) guidelines and the European Union's Pharmacovigilance System Master File (PSMF), were developed to standardize pharmacovigilance practices across different regions.

5. Technological Advancements: The evolution of technology has played a significant role in advancing pharmacovigilance practices. Electronic databases and computerized systems have streamlined the collection, analysis, and reporting of adverse event data, enabling faster detection of potential safety concerns.

6. Pharmacovigilance in the Digital Age: With the advent of social media and digital health technologies, pharmacovigilance has entered a new era of real-time monitoring and surveillance. Social media platforms and online forums provide valuable sources of patient-reported adverse events, complementing traditional pharmacovigilance data sources.

7. Future Trends and Challenges: The future of pharmacovigilance is likely to be shaped by emerging trends such as artificial intelligence, big data analytics, and personalized medicine. However, challenges such as underreporting of adverse events, data quality issues, and resource constraints continue to pose significant barriers to the effective implementation of pharmacovigilance programs.

تعليقات

إرسال تعليق

المشاركات الشائعة من هذه المدونة

Tips on how to write a meta-analysis by Dr. Nehad Jaser

  Tips on how to write a meta-analysis   Writing a meta-analysis is a difficult endeavor that demands careful planning, strict methodology, and a clear presentation. A meta-analysis is a statistical approach that integrates the findings of several studies on a single topic or question to produce an overall assessment of the magnitude of the effect or the strength of the association between two variables. A meta-analysis can also investigate the sources of heterogeneity or variance among the studies, as well as assess the validity of various theoretical assumptions or hypotheses. Conducting and publishing a meta-analysis involves numerous steps, and various fields may have different standards and criteria. However, the following is a general framework for producing a meta-analysis: Specify the scope and research query of the meta-analysis. It is essential that the research query be precise, targeted, and pertinent to the field of study. Encompass the criteri...
قراءة المزيد

Centers for Disease Control and Prevention (CDC) categorizes germs into three main categories

The Centers for Disease Control and Prevention (CDC) categorizes germs into three main categories—urgent, serious, and concerning—based on their potential to cause public health threats and the urgency of action required to address them. Additionally, the CDC maintains a watch list of pathogens that are closely monitored due to emerging resistance or other factors. Here's an overview of each category along with examples: Urgent Threats : Urgent threats are pathogens that pose an immediate public health risk due to their high levels of antibiotic resistance, limited treatment options, and potential for widespread transmission. Examples include: Carbapenem-resistant Acinetobacter Drug-resistant Candida Auris Clostridioides difficile Carbapenem-resistant Enterobacteriaceae (CRE) Drug-Resistant Neisseria Gonorrhoeae Serious Threats : Serious threats are pathogens that are moder...
قراءة المزيد

The history of herbal medicine

  The history of herbal medicine is as ancient as human civilization itself, with evidence of medicinal plant usage dating back thousands of years. Herbal medicine, also known as botanical medicine or phytotherapy, involves the use of plants and plant extracts to prevent, alleviate, or treat various ailments. Throughout history, different cultures around the world have developed their own systems of herbal medicine, drawing upon indigenous plants and traditional knowledge. Ancient Civilizations : The roots of herbal medicine can be traced to ancient civilizations such as Egypt, China, India, and Mesopotamia. In ancient Egypt, for example, medicinal plants like aloe, garlic, and castor oil were documented in medical texts like the Ebers Papyrus (circa 1550 BCE). Similarly, traditional Chinese medicine (TCM) has a rich history of herbal remedies, as evidenced by texts like the "Shennong Ben Cao Jing," which dates back to around 300 BCE. Classical Greece and Rome : The Greek phy...
قراءة المزيد